MRNA — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

16.26

Margin Of Safety %

Put/Call OI Ratio

0.85

EPS Next Q Diff

2.25

EPS Last/This Y

-1.39

EPS This/Next Y

3.93

Price

46.88

Target Price

46.8

Analyst Recom

2.96

Performance Q

-6.74

Upside

-708.2%

Beta

1.06

Ticker: MRNA

22 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-04-23	MRNA	52.84	0.81	0.71	636199
2026-04-24	MRNA	50.71	0.81	0.15	642211
2026-04-27	MRNA	48.7	0.83	0.73	633758
2026-04-28	MRNA	47.12	0.84	0.54	647323
2026-04-29	MRNA	45.71	0.83	1.44	651665
2026-04-30	MRNA	46.2	0.85	0.54	660065
2026-05-01	MRNA	45.36	0.82	0.16	690646
2026-05-04	MRNA	47.32	0.85	0.62	669461
2026-05-05	MRNA	46.7	0.85	0.34	680420
2026-05-06	MRNA	48.76	0.85	0.23	684023
2026-05-07	MRNA	48.54	0.81	0.07	703244
2026-05-08	MRNA	54.37	0.80	0.13	716430
2026-05-11	MRNA	52.89	0.79	0.39	710602
2026-05-12	MRNA	53.25	0.80	0.41	741899
2026-05-13	MRNA	50.37	0.80	0.33	752054
2026-05-14	MRNA	50.04	0.81	0.12	754295
2026-05-15	MRNA	49.06	0.78	0.15	766833
2026-05-18	MRNA	48.07	0.89	0.19	637443
2026-05-19	MRNA	45.73	0.88	0.57	643331
2026-05-20	MRNA	48.14	0.88	0.43	652361
2026-05-21	MRNA	47.18	0.88	0.11	657733
2026-05-22	MRNA	46.88	0.85	0.16	674127
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

22 items 1 of 1

21 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-04-23	MRNA	52.85	-15.1	-822.3	-7.24
2026-04-24	MRNA	50.72	-15.1	-864.0	-7.24
2026-04-27	MRNA	48.69	-15.1	-862.1	-7.38
2026-04-28	MRNA	47.11	-36.0	-897.3	-7.64
2026-04-30	MRNA	45.90	-57.0	-1079.7	-8.25
2026-05-01	MRNA	45.35	-57.0	-994.8	-8.25
2026-05-04	MRNA	47.32	-57.0	-1278.6	-8.25
2026-05-05	MRNA	46.72	7.1	-643.9	-8.80
2026-05-06	MRNA	48.76	7.1	-913.9	-8.80
2026-05-07	MRNA	48.54	8.5	-367.4	-8.71
2026-05-08	MRNA	54.33	8.5	-919.9	-8.71
2026-05-11	MRNA	52.91	8.5	-468.2	-8.69
2026-05-12	MRNA	53.24	8.5	-618.9	-8.69
2026-05-13	MRNA	50.40	8.5	-343.3	-8.69
2026-05-14	MRNA	50.04	8.5	-553.6	-8.69
2026-05-15	MRNA	49.06	8.5	-498.7	-8.69
2026-05-18	MRNA	48.10	8.5	-499.2	-8.65
2026-05-19	MRNA	45.71	8.5	-357.4	-8.65
2026-05-20	MRNA	48.12	8.5	-835.6	-8.65
2026-05-21	MRNA	47.26	8.5	-504.8	-8.65
2026-05-22	MRNA	46.88	8.5	-550.4	-8.65
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

21 items 1 of 1

22 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-04-23	MRNA	-0.58	6.49	16.71
2026-04-24	MRNA	-0.59	6.49	16.71
2026-04-27	MRNA	-0.59	6.63	16.37
2026-04-28	MRNA	-0.59	6.63	16.37
2026-04-29	MRNA	-0.59	6.63	16.37
2026-04-30	MRNA	-0.59	6.63	16.37
2026-05-01	MRNA	-0.59	6.63	16.37
2026-05-04	MRNA	-0.59	6.21	16.37
2026-05-05	MRNA	-0.60	6.21	16.37
2026-05-06	MRNA	-0.60	6.21	16.37
2026-05-07	MRNA	-0.60	6.21	16.36
2026-05-08	MRNA	-0.60	6.21	16.36
2026-05-11	MRNA	-0.60	6.36	16.37
2026-05-12	MRNA	-0.60	6.36	16.06
2026-05-13	MRNA	-0.60	6.36	16.06
2026-05-14	MRNA	-0.60	6.36	16.06
2026-05-15	MRNA	-0.60	6.36	16.06
2026-05-18	MRNA	-0.60	7.04	16.05
2026-05-19	MRNA	-0.76	7.04	16.05
2026-05-20	MRNA	-0.76	7.04	16.05
2026-05-21	MRNA	-0.76	7.04	16.05
2026-05-22	MRNA	-0.76	7.04	16.26
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

22 items 1 of 1

Last Quarter Act. EPS

-3.4

Avg. EPS Est. Current Quarter

-2.09

Avg. EPS Est. Next Quarter

-1.15

Insider Transactions

-0.76

Institutional Transactions

7.04

Beta

1.06

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

919

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

90.6

Max Drawdown 5-Year %

-95.4

Target Price

46.8

P/E

Forward P/E

PEG

P/S

8.36

P/B

2.51

P/Free Cash Flow

EPS

-8.15

Average EPS Est. Cur. Y

-8.65

EPS Next Y. (Est.)

-4.73

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-143.55

Relative Volume

0.55

Return on Equity vs Sector %

-70.2

Return on Equity vs Industry %

-54.6

EPS 1 7Days Diff

EPS 1 30Days Diff

-1.41

EBIT Estimation

-550.4

◆ MRNA Healthcare

$46.90

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

14/20

Pullback

19/25

Volume

11/15

Valuation

4/20

TP/AR

2/10

Options

4/10

RSI

43.3

Range 1M

20.4%

Sup Dist

0.8%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

7/25

Growth

11/30

Estimates

2/20

Inst/Vol

6/15

Options

7/10

EPS Yr

-18.4%

EPS NY

45.1%

52W%

66.1%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🔴 SELL -0.2% upside

Quality

2/30

Valuation

2/30

Growth

11/25

Stability

8/10

LT Trend

1/5

Upside

-0.2%

Quality

Moderna, Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 4700

Moderna, Inc., a biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally. The company's respiratory vaccines include spikevax, mNEXSPIKE, mRESVIA, COVID, RSV, seasonal influenza, combination, and pandemic influenza vaccine; latent vaccines comprise cytomegalovirus, epstein-barr virus, and human immunodeficiency virus vaccines; enteric viruses include norovirus; public health vaccines consist of Zika, Nipah, and Mpox vaccines; and bacterial diseases vaccines, such as lyme vaccines. It also provides oncology therapeutics, such as intismeran autogene, cancer antigen therapy, t-cell engager, and cell therapy enhancer; and rare disease products, including propionic and methylmalonic acidemia, and cystic fibrosis. It has strategic alliances and collaborations with Merck & Co., Inc; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; immatics N.V.; Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; The Bill & Melinda Gates Foundation; and OpenAI. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.

MRNA

Latest News

—

Caricamento notizie per MRNA…

stock quote shares MRNA – Moderna, Inc. Stock Price stock today

news today MRNA – Moderna, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch MRNA – Moderna, Inc. yahoo finance google finance

stock history MRNA – Moderna, Inc. invest stock market

stock prices MRNA premarket after hours

ticker MRNA fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: MRNA

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y